Zobrazeno 1 - 10
of 403
pro vyhledávání: '"anti-tuberculosis drug"'
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Tuberculosis (TB) has been troubling humans for hundreds of years, is a highly infectious disease caused by Mycobacterium tuberculosis (Mtb) infection, Mtb can infect almost all organs of the body and is one of the deadly infectious diseases in the w
Externí odkaz:
https://doaj.org/article/b4ecb3c3c4f34935ac607629eea18e14
Autor:
Chun-Kai Huang, Jei-Yie Huang, Chin-Hao Chang, Shang-Jie Tsai, Chin-Chung Shu, Hao-Chien Wang, Kuo-Liong Chien
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 57, Iss 3, Pp 498-508 (2024)
Background: Tuberculosis (TB) remains prevalent worldwide, and anti-TB drugs are associated with drug-induced liver injury (DILI). Statins have pleiotropic effects which may decrease inflammation and achieve immunomodulation. However, few studies hav
Externí odkaz:
https://doaj.org/article/3f66a3217ea8436e9d6bcc67ec0076dc
Publikováno v:
Genel Tıp Dergisi, Vol 34, Iss 2, Pp 190-194 (2024)
Background/Aim: Tuberculosis remains a major global health problem with a high morbidity and mortality rate, approximately a quarter of the population is infected with tuberculosis. Drug susceptibility testing is an essential tool for identifying and
Externí odkaz:
https://doaj.org/article/81c3b7f9070e4d6bbee2d5689f845026
Publikováno v:
BMC Microbiology, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background The pathogenesis of anti-tuberculosis (TB) drug-induced liver injury (ADLI) is complicated and remains unclear. We aimed to analyse the relationship between the characteristics of gut microbiota and ADLI in Mongolian and Han patie
Externí odkaz:
https://doaj.org/article/179126317bad4d4f98e30e96ae051b6e
Publikováno v:
Shanghai yufang yixue, Vol 35, Iss 2, Pp 103-109 (2023)
ObjectiveThe study utilized human transcriptome microarray to explore biomarkers for diagnosing drug-induced liver injury （DILI） caused by anti-tuberculosis drugs.MethodsA 6-month follow-up study was conducted on 152 patients treated with anti-tu
Externí odkaz:
https://doaj.org/article/744b0b203d2646d982030c7017084716
Autor:
Fang Cheng, Xian-Gao Jiang, Shi-Lin Zheng, Te Wu, Qiang Zhang, Xin-Chun Ye, Saiduo Liu, Ji-Chan Shi
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Considering the genetic characteristics of people with anti-tuberculosis (TB)-drug-induced liver injury (ATDILI), genetic factors and their consequences for treatment need to be studied.Objective: The correlation between N-acetyltransfera
Externí odkaz:
https://doaj.org/article/3028e4c89e5d41a1956df6d4da159c1c
Autor:
Anak Agung Fendy Tri Wicaksana, Bramantono Bramantono, Musofa Rusli, M Vitanata Arfijanto, Usman Hadi
Publikováno v:
Acta Medica Indonesiana, Vol 55, Iss 3 (2023)
Tuberculosis (TB) is generally known as an infectious disease caused by Mycobacterium tuberculosis. Not only the lungs, TB can also infect various other organs. Pancreatic TB is a rare manifestation of extrapulmonary TB infection accounting for only
Externí odkaz:
https://doaj.org/article/72e23ce4348b4a069955b7ed8f03d8a5
Autor:
Ni Luh Putu Eka Arisanti, Ni Putu Ayu Widiasari, Ni Wayan Candrawati, Ida Ayu Jasminarti Dwi Kusumawardani, Ida Bagus Ngurah Rai, Made Ary Sarasmita
Publikováno v:
Jurnal Respirasi, Vol 8, Iss 3, Pp 153-160 (2022)
Introduction: Globally, drug-resistant tuberculosis (TB) still has a high number of cases. Pregnant women are one of the high-risk populations for TB infection, especially multidrug resistance (MDR)/Rifampicin resistance (RR) TB. Physiological differ
Externí odkaz:
https://doaj.org/article/0e9c05b1df48427c914cc87033f12bfd
Autor:
Sizeka A. Mashele, Helen C. Steel, Maborwa T. Matjokotja, Sam S.M. Rasehlo, Ronald Anderson, Moloko C. Cholo
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 29, Iss , Pp 343-352 (2022)
ABSTRACT: Objectives: The chemotherapeutic regimens of patients with drug-susceptible (DS)- tuberculosis (TB) comprise four primary anti-TB drugs: rifampicin (RMP), isoniazid (INH), ethambutol (EMB) and pyrazinamide (PZA), administered for six-to-nin
Externí odkaz:
https://doaj.org/article/b9a699187e2543b3b1fc83315fe135c4
Autor:
Moo-Sang Chong, Kyutaeg Lee
Publikováno v:
Korean Journal of Clinical Laboratory Science, Vol 54, Iss 2, Pp 125-132 (2022)
The prevalence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) are increasing. We analyzed the patterns of drug resistance and tracking period days of acquiring anti-mycobacterial resistance. From January 2010 to Decembe
Externí odkaz:
https://doaj.org/article/329f6cebb7fe4b5287b018b32f17f085